NCT01030432 Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin Status COMPLETED Phase PHASE2
NCT01024231 Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma Status COMPLETED Phase PHASE1
NCT01024101 Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01024062 Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT01023204 Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer Status COMPLETED Phase PHASE2
NCT01022801 A Phase II Dose Response Study in Japan in Chronic Hepatitis B Status COMPLETED Phase PHASE2
NCT01020565 A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection Status COMPLETED Phase PHASE2
NCT01019070 Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032 Status COMPLETED Phase PHASE1
NCT01018745 Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan Status COMPLETED Phase PHASE1
NCT01017575 Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin) Status COMPLETED Phase PHASE2
NCT01017367 Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT01016912 Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients Status COMPLETED Phase PHASE2
NCT01012895 Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care Status COMPLETED Phase PHASE2
NCT01006603 Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin Status COMPLETED Phase PHASE4
NCT01006590 Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01004159 Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan Status TERMINATED Phase PHASE2
NCT01003990 Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access Status COMPLETED Phase PHASE3
NCT01002807 Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State Status COMPLETED Phase PHASE1
NCT01001832 Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients Status COMPLETED Phase PHASE2/PHASE3